| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 5 | / | 2023 | ||||||||
| Date of issue: | 2023-02-24 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Acquisition of treasury shares | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces: With a reference to the public notice from 29 July 2020, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 17 February 2023 up to and including 23 February 2023. Krka acquired 3,785 treasury shares in the total value of EUR 403,115 on the Ljubljana Stock Exchange as follows: - on 17 February 2023: 574 shares at a VWAP of EUR 106.96, - on 20 February 2023: 993 shares at a VWAP of EUR 106.57, - on 21 February 2023: 865 shares at a VWAP of EUR 106.32, - on 22 February 2023: 843 shares at a VWAP of EUR 106.00 and - on 23 February 2023: 510 shares at a VWAP of EUR 107.00. Price is calculated as volume weighted average price (VWAP). Ilirika d.d., Intercapital d.d, and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached. The total number of treasury shares prior to these transactions was 1,795,058 representing 5.474% of all shares issued. The total number of treasury shares after these transactions is 1,798,843 representing 5.485% of all shares issued. The notice will be published on the Company's website (www.krka.biz) from 24 February 2023 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Detailed report on acquisition of treasury shares.pdf | Detailed report on acquisition of treasury shares | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-02-24 | Jože Colarič | President of the Management Board and CEO | |||
Detailed report on acquisition of treasury shares.pdf
